# Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)

> **NCT02215265** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Lisette Nixon** · enrollment: 1269 (estimated)

## Conditions studied

- Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer

## Interventions

- **DRUG:** Cisplatin
- **RADIATION:** Postoperative radiotherapy

## Key facts

- **NCT ID:** NCT02215265
- **Lead sponsor:** Lisette Nixon
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-10
- **Primary completion:** 2027-10
- **Final completion:** 2028-04
- **Target enrollment:** 1269 (ESTIMATED)
- **Last updated:** 2025-02-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02215265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02215265, "Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02215265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*